1Sigurs N,Bjarnason R,Sigurbergsson F,et al.Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.Am J Respir Crit Care Med,2000,161(5):1501-1507.
2Raghu Pathy R. Thl -type immunity is incompatible with successful pregnancy. Immunol Today. 1997, 18(10) :478.
3Wilczynski JR, Tchorzewski H, Glowacka E, et al.Cytokine secretion by decidual lymphocytes in transient hypertension of pregnancy and preeclampsia. Mediators Inflamm, 2002, 11(2) :105.
4Rein DT, Schondorf T, Gohring UJ, et cd. Cytokine experession in peripheral blood lymphocytes indicates a switch to T helper cells in patients with preeclampsia. J Reprod Immunol. 2002, 54:133.
6Paolo M, Renzi MD, Jean P, et al. Cellular immunity is activated and a Th2 response is associated with early wheezing in infants after bronchiolitis[J]. J Pediatrics, 1997, 130 (4) : 584.
7Aivazis V, Hatzimichail A, Papachristou A, et al. Clinical evaluation and changes of the respiratory epithelium function after administration of Pidotimod in Greek children with recurrent respiratory tract infections [J]. Minerva Pediatr, 2002, 54(4): 315
8Benetti GP, Fugazza L, Stramba Badiale M, et al. Ex vivo evaluation of pidotimod activity on cell-mediated immunity [J].Arzneimittelforschung, 1994, 44(12A): 1476.
9Migliorati G, Coppi G, D'Adamio F, et al. Immunopharmacology of Pidotimod: effect on natural killer cell activity and thymocyte cell death [J]. Pharmacol Res, 1992, 26 (Suppl 2): 154.
10Passali D, Calearo C, Conticello S. Pidotimod in the management of recurrent pharyngotonsillar infections in childhood[J]. Arzneimittelforschung, 1994, 44(12A): 1511.
